Argan, Inc.
AGX · NYSE
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.53 | 0.43 | -0.81 | 1.28 |
| FCF Yield | 4.06% | 0.98% | 1.67% | 2.33% |
| EV / EBITDA | 120.39 | 85.70 | 73.29 | 52.66 |
| Quality | ||||
| ROIC | 5.86% | 7.38% | 4.92% | 7.39% |
| Gross Margin | 18.69% | 18.62% | 19.03% | 20.48% |
| Cash Conversion Ratio | 5.61 | 0.98 | 1.57 | 1.42 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.15% | 24.11% | 25.68% | 24.31% |
| Free Cash Flow Growth | 422.40% | -5.70% | -19.33% | 47.99% |
| Safety | ||||
| Net Debt / EBITDA | -9.39 | -4.72 | -7.20 | -4.28 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 133.10 | 577.69 |
| Cash Conversion Cycle | 16.63 | 33.87 | 41.01 | 45.76 |